Key points Heart surgery requiring the heart-lung machine (cardiopulmonary bypass) saves lives but can cause brain and kidney problems in many ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

GLP-1 medications are reshaping the weight management landscape — and beginning to take a bite out of bariatric surgery volumes in hospitals. Between 2022 and 2023, bariatric surgery rates fell 25.6% ...

Biotechnology firm Humacyte’s (HUMA) shares have declined since the company presented its fourth-quarter and full-year 2024 results. The ...

In his speech to the Board of Trade, Metrolinx CEO Michael Lindsay said while progress might seem "incremental," transit projects are moving forward.

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

The influencer’s followers accused her of “lying” and “blocking people” who questioned her transformation for months before ...